ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      64,918.52
      -0.34%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Graphite Bio Inc (GRPH)

      7. Graphite Bio Inc (GRPH) News

      GRPH

      Graphite Bio (GRPH)

      Graphite Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GRPH
      DateTimeSourceHeadlineSymbolCompany
      06/06/20234:06PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GRPHGraphite Bio Inc
      05/11/20234:13PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GRPHGraphite Bio Inc
      03/20/20234:18PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GRPHGraphite Bio Inc
      03/20/20234:12PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:GRPHGraphite Bio Inc
      03/20/20234:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      03/20/20234:05PMBusiness WireGraphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2022 Financial ResultsNASDAQ:GRPHGraphite Bio Inc
      02/22/20235:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      02/22/20234:05PMBusiness WireGraphite Bio Announces Process to Explore Strategic Alternatives and Corporate RestructuringNASDAQ:GRPHGraphite Bio Inc
      01/05/20234:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      01/05/20234:05PMBusiness WireGraphite Bio Announces Voluntary Pause of Phase 1/2 CEDAR Study of nulabeglogene autogedtemcel (nula-cel) for Sickle Cell DiseaseNASDAQ:GRPHGraphite Bio Inc
      12/12/20228:42AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GRPHGraphite Bio Inc
      12/12/20226:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      12/11/202210:00AMBusiness WireGraphite Bio Presents Preclinical Data for Novel Sequencing Method Used to Determine Gene Editing Outcomes at 64th ASH Annual MeetingNASDAQ:GRPHGraphite Bio Inc
      11/21/20228:00AMBusiness WireGraphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx ConferenceNASDAQ:GRPHGraphite Bio Inc
      11/13/202211:05PMTipRanksBTIG Sticks to Their Buy Rating for Graphite Bio (GRPH)NASDAQ:GRPHGraphite Bio Inc
      11/13/202210:55PMTipRanksSVB Securities Sticks to Its Buy Rating for Graphite Bio (GRPH)NASDAQ:GRPHGraphite Bio Inc
      11/10/20228:49PMTipRanksGraphite Bio (GRPH) Receives a Hold from RBC CapitalNASDAQ:GRPHGraphite Bio Inc
      11/09/20224:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      11/09/20224:05PMBusiness WireGraphite Bio Reports Recent Business Progress and Third Quarter 2022 Financial ResultsNASDAQ:GRPHGraphite Bio Inc
      11/03/20229:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      11/03/20229:05AMBusiness WireGraphite Bio Announces Abstracts Accepted for Upcoming 64th ASH Annual Meeting and ExpositionNASDAQ:GRPHGraphite Bio Inc
      10/11/20228:00AMBusiness WireGraphite Bio Announces Participation in 50th Annual Sickle Cell Disease Association of America National ConventionNASDAQ:GRPHGraphite Bio Inc
      09/06/20228:00AMBusiness WireGraphite Bio Announces Participation in Morgan Stanley 20th Annual Global Healthcare ConferenceNASDAQ:GRPHGraphite Bio Inc
      08/16/20224:47AMTipRanksBTIG Reaffirms Their Buy Rating on Graphite Bio (GRPH)NASDAQ:GRPHGraphite Bio Inc
      08/16/20224:46AMTipRanksGraphite Bio (GRPH) Receives a Buy from SVB SecuritiesNASDAQ:GRPHGraphite Bio Inc
      08/11/20224:12PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GRPHGraphite Bio Inc
      08/11/20224:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
      08/11/20224:05PMBusiness WireGraphite Bio Reports Recent Business Progress and Second Quarter 2022 Financial ResultsNASDAQ:GRPHGraphite Bio Inc
      08/11/20228:16AMBusiness WireGraphite Bio Doses First Patient with Investigational Gene Editing Therapy GPH101 for Sickle Cell DiseaseNASDAQ:GRPHGraphite Bio Inc
      08/11/20228:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
       Showing the most relevant articles for your search:NASDAQ:GRPH